Privia Health Group, Inc. - PRVA - Fundamentals

‌
‌

‌

Let's get started...

‌

Breakdown	2018 12/31	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	658	786	817	966	1,357	1,658	1,736	2,123	605,490	📊
Revenue Growth (1Y)	--	+19.58%	+3.91%	+18.25%	+40.41%	+22.19%	+4.74%	+22.26%	+28422.60%	📊
Revenue Growth (5Y)	--	--	--	--	+106.30%	+110.81%	+112.51%	+119.71%	+62565.83%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue	601	718	734	903	1,222	1,496	1,560	1,923	1,487	📊
Cost of Revenue Growth (1Y)	--	+19.42%	+2.31%	+22.88%	+35.38%	+22.45%	+4.23%	+23.33%	-22.68%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+103.26%	+108.42%	+112.33%	+113.10%	+64.76%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Gross Profit	56	68	83	64	135	162	177	200	156	📊
Gross Profit Growth (1Y)	--	+21.28%	+20.61%	-22.91%	+111.71%	+19.82%	+9.51%	+12.82%	-21.98%	📊
Gross Profit Growth (5Y)	--	--	--	--	+138.73%	+135.86%	+114.15%	+213.41%	+144.51%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Operating Expenses	54	52	57	281	154	141	160	165	596,552	📊
Operating Expenses Growth (1Y)	--	-3.49%	+9.14%	+391.41%	-45.25%	-8.48%	+13.50%	+3.39%	+360816.49%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+183.41%	+168.75%	+179.48%	-41.20%	+212121.95%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Sell General Administrative	53	51	55	279	149	134	153	165,288	85,418	📊
Research and Development	0	0	0	0	0	0	0	0	--	📊
Other Income Expenses	1	1	2	2	5	7	7	-165,123	511,134	📊
EBITDA	3	17	27	-215	-15	27	24	54	11,989	📊
EBITDA Growth (1Y)	--	+441.96%	+55.66%	-889.67%	+93.23%	+286.81%	-10.79%	+122.04%	+22165.38%	📊
EBITDA Growth (5Y)	--	--	--	--	-550.91%	+55.42%	-10.92%	+125.05%	+5676.91%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	1	1	2	2	5	7	7	10	3,289	📊
Operating Income	2	16	25	-217	-19	21	17	34	7,451	📊
Operating Income Growth (1Y)	--	+645.34%	+58.01%	-956.72%	+91.21%	+207.99%	-17.76%	+101.60%	+21664.33%	📊
Operating Income Growth (5Y)	--	--	--	--	-987.33%	+28.56%	-33.09%	+115.74%	+3526.76%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Interest Expense	6	7	2	1	0	0	0	0	--	📊
Pre Tax Income	-4	9	23	-219	-19	29	28	44	9,346	📊
Tax Provision	-0	1	-7	-28	-7	8	11	14	5,612	📊
NET INCOME	-3	8	31	-191	-9	23	14	23	3,083	📊
Net Income Growth (1Y)	--	+370.83%	+278.99%	-710.19%	+95.50%	+368.83%	-37.67%	+59.33%	+13350.41%	📊
Net Income Growth (5Y)	--	--	--	--	-182.03%	+179.95%	-53.96%	+112.02%	+1716.95%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	📊
Basic EPS	-0.03	0.08	0.3	-1.77	-0.11	0.2	0.12	0.19	0.17	📊
Diluted EPS	-0.03	0.08	0.3	-1.77	-0.11	0.19	0.11	0.18	0.16	📊
Basic Average Shares	103	106	106	108	111	117	119	122	123	📊
Diluted Average Shares	103	106	106	108	111	125	126	129	130	📊

Breakdown

2018

12/31

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

658

786

817

966

1,357

1,658

1,736

2,123

605,490

📊

Revenue Growth (1Y)

+19.58%

+3.91%

+18.25%

+40.41%

+22.19%

+4.74%

+22.26%

+28422.60%

📊

Revenue Growth (5Y)

+106.30%

+110.81%

+112.51%

+119.71%

+62565.83%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

601

718

734

903

1,222

1,496

1,560

1,923

1,487

📊

Cost of Revenue Growth (1Y)

+19.42%

+2.31%

+22.88%

+35.38%

+22.45%

+4.23%

+23.33%

-22.68%

📊

Cost of Revenue Growth (5Y)

+103.26%

+108.42%

+112.33%

+113.10%

+64.76%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

135

162

177

200

156

📊

Gross Profit Growth (1Y)

+21.28%

+20.61%

-22.91%

+111.71%

+19.82%

+9.51%

+12.82%

-21.98%

📊

Gross Profit Growth (5Y)

+138.73%

+135.86%

+114.15%

+213.41%

+144.51%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

281

154

141

160

165

596,552

📊

Operating Expenses Growth (1Y)

-3.49%

+9.14%

+391.41%

-45.25%

-8.48%

+13.50%

+3.39%

+360816.49%

📊

Operating Expenses Growth (5Y)

+183.41%

+168.75%

+179.48%

-41.20%

+212121.95%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

279

149

134

153

165,288

85,418

📊

Research and Development

📊

Other Income Expenses

-165,123

511,134

📊

EBITDA

-215

-15

11,989

📊

EBITDA Growth (1Y)

+441.96%

+55.66%

-889.67%

+93.23%

+286.81%

-10.79%

+122.04%

+22165.38%

📊

EBITDA Growth (5Y)

-550.91%

+55.42%

-10.92%

+125.05%

+5676.91%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

3,289

📊

Operating Income

-217

-19

7,451

📊

Operating Income Growth (1Y)

+645.34%

+58.01%

-956.72%

+91.21%

+207.99%

-17.76%

+101.60%

+21664.33%

📊

Operating Income Growth (5Y)

-987.33%

+28.56%

-33.09%

+115.74%

+3526.76%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-4

-219

-19

9,346

📊

Tax Provision

-0

-7

-28

-7

5,612

📊

NET INCOME

-3

-191

-9

3,083

📊

Net Income Growth (1Y)

+370.83%

+278.99%

-710.19%

+95.50%

+368.83%

-37.67%

+59.33%

+13350.41%

📊

Net Income Growth (5Y)

-182.03%

+179.95%

-53.96%

+112.02%

+1716.95%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.03

0.08

0.3

-1.77

-0.11

0.2

0.12

0.19

0.17

📊

Diluted EPS

-0.03

0.08

0.3

-1.77

-0.11

0.19

0.11

0.18

0.16

📊

Basic Average Shares

103

106

108

111

117

119

122

123

📊

Diluted Average Shares

103

106

108

111

125

126

129

130

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-353.25%
Next Earnings
Market cap	2.69B (USD)
EPS (TTM)	0.17 ($)
P/E (TTM)	127.24 ($)
Last Close	21.63

Next Earnings
Market cap	2.69B (USD)
EPS (TTM)	0.17 ($)
P/E (TTM)	127.24 ($)
Last Close	21.63 ($)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-353.25%
Next Earnings
Market cap	2.69B (USD)
EPS (TTM)	0.17 ($)
P/E (TTM)	127.24 ($)
Last Close	21.63

Next Earnings
Market cap	2.69B (USD)
EPS (TTM)	0.17 ($)
P/E (TTM)	127.24 ($)
Last Close	21.63 ($)